Catalog No.
EVV24011
Expression system
Mammalian cells
Species
Influenza A virus (A/Jiangsu/1/2018 (H7N4))
Protein length
Leu29-Lys470
Predicted molecular weight
51.95 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
AUO38257.1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
neuraminidase, NA
No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
hnRNPM regulates influenza A virus replication through distinct mechanisms in human and avian cells: implications for cross-species transmission., PMID:40434105
Phylogenetic Analysis and Spread of HPAI H5N1 in Middle Eastern Countries Based on Hemagglutinin and Neuraminidase Gene Sequences., PMID:40431745
Shared host genetic landscape of respiratory viral infection., PMID:40372436
Binding antibody titers against the hemagglutinin and neuraminidase correlate with protection against medically attended influenza A and B disease., PMID:40358209
Influenza virus: Genomic insights, evolution, and its clinical presentation., PMID:40345348
Seroprevalence of anti-influenza antibodies in humans and characterization of seasonal influenza viruses isolated in Russia during the 2023-2024 flu season., PMID:40307541
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
The Ongoing Epidemics of Seasonal Influenza A(H3N2) in Hangzhou, China, and Its Viral Genetic Diversity., PMID:40284969
Comparative Mutational Analysis and the Glycosylation Patterns of a Peruvian Isolated Avian Influenza A Virus H5N1: Exploring Possible Viral Spillover Events Within One Health Approach., PMID:40284894
Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model., PMID:40267617
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination., PMID:40265888
Design, Synthesis and In Vivo Evaluation of a Candidate Fusion Epitopic Construct Vaccine Based on M2e, HA1, HA2, NA and NP Fragments of the Highly Pathogenic Avian H5N1 Influenza Virus., PMID:40256578
Evolutionary dynamics and molecular epidemiology of H1N1 pandemic 2009 influenza A viruses across swine farms in Denmark., PMID:40235651
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses., PMID:40193611
Immunogenicity and protective efficacy of an inactivated bivalent vaccine containing two recombinant H1N1 and H3N2 swine influenza virus strains., PMID:40192841
Machine learning methods for predicting human-adaptive influenza A virus reassortment based on intersegment constraint., PMID:40190733
Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets., PMID:40186991
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody., PMID:40178595
Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus., PMID:40145257
Simultaneous Packaging of Two Different RNA Segments into an Influenza C Virus-like Particle Occurs Inefficiently., PMID:40143279
Synergistic Antiviral Activity of Xanthan Gum and Camostat Against Influenza Virus Infection., PMID:40143232
Host Serine Proteases and Antiviral Innate Immunity as Potential Therapeutic Targets in Influenza A Virus Infection-Induced COPD Exacerbations., PMID:40141187
A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e., PMID:40139072
Quantification of intracellular influenza A virus protein dynamics in different host cells after seed virus adaptation., PMID:40126655
A novel reassorted swine H3N2 influenza virus demonstrates an undetected human-to-swine spillover in Latin America and highlights zoonotic risks., PMID:40073501
Clade 2.3.4.4b H5N1 neuraminidase has a long stalk, which is in contrast to most highly pathogenic H5N1 viruses circulating between 2002 and 2020., PMID:40008897
A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection., PMID:39982912
Neuraminidase reassortment and oseltamivir resistance in clade 2.3.4.4b A(H5N1) viruses circulating among Canadian poultry, 2024., PMID:39964293
Evaluation of an N1 NA antibody-specific enzyme-linked lectin assay for detection of H5N1 highly pathogenic avian influenza virus infection in vaccinated birds., PMID:39956396
Deglycosylation and truncation in the neuraminidase stalk are functionally equivalent in enhancing the pathogenicity of a high pathogenicity avian influenza virus in chickens., PMID:39950775
Rapid surge of reassortant A(H1N1) influenza viruses in Danish swine and their zoonotic potential., PMID:39945729
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus., PMID:39879304
Genetic and Molecular Characterization of Avian Influenza A(H9N2) Viruses from Live Bird Markets (LBM) in Senegal., PMID:39861862
Hovenia dulcis Thunb. Honey Exerts Antiviral Effect Against Influenza A Virus Infection Through Mitochondrial Stress-Mediated Enhancement of Innate Immunity., PMID:39857405
Molecular characterization and genetic analysis of highly pathogenic H5N1 clade 2.3.4.4b in seagulls from Dukan Lake, Iraq., PMID:39841342
High-resolution melting analysis for detection of nucleotide mutation markers in the polymerase-acidic (PA) gene of influenza virus that are associated with baloxavir marboxil resistance., PMID:39762649
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens., PMID:39756216
Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines., PMID:39754936
Identification of a broad-inhibition influenza neuraminidase antibody from pre-existing memory B cells., PMID:39740671
Replication kinetics, pathogenicity and virus-induced cellular responses of cattle-origin influenza A(H5N1) isolates from Texas, United States., PMID:39727152
Evidence of an emerging triple-reassortant H3N3 avian influenza virus in China., PMID:39725881
Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil., PMID:39709805
PB2 627V and HA 217 sites synergistically affect the lethality of H9N2 in mice., PMID:39701421
Antiviral-effect of nitrogen-containing compounds isolated from Sarcodon imbricatus on influenza A virus through regulation of ZBP-1 mediated necroptosis., PMID:39671721
Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?, PMID:39654774
The evolution of hemagglutinin-158 and neuraminidase-88 glycosylation sites modulates antigenicity and pathogenicity of clade 2.3.2.1 H5N1 avian influenza viruses., PMID:39647217
A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine., PMID:39645432
Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model., PMID:39636110
Epidemiological and genetic characterization of the influenza A (H1N1) virus in Hangzhou City in 2023., PMID:39635219
For research use only. Not for human or drug use.
